Examining adaptive functioning in pediatric patients with congenital heart disease

Corinne M Anton1,2,3, Kelli N Triplett2,3,4, Ila A Iverson2

  • 1Department of Cardiology, Children's Health - Children's Medical Center, Dallas, TX, USA.

Insights

Young children with congenital heart disease often show lower adaptive skills, impacting daily living. This study highlights the link between adaptive functioning, cognitive abilities, and factors like genetic syndromes and parental education.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Science
  • Child Psychology

Background:

  • Congenital heart disease (CHD) is linked to neurodevelopmental impairments in children.
  • Adaptive functioning is crucial for independence and quality of life, yet poorly understood in young children with CHD.
  • Early identification and support for adaptive skills are vital for this population.

Purpose of the Study:

  • To describe adaptive functioning in young children (ages 2-5) with a history of congenital heart disease.
  • To examine the relationship between adaptive skills, developmental status, and cognitive abilities in this cohort.
  • To identify factors associated with variations in adaptive functioning.

Main Methods:

  • Retrospective analysis of clinical registry data from 104 children (ages 2-5) with CHD.
  • Inclusion of English-monolingual and Spanish-bilingual participants evaluated at a cardiac neurodevelopmental program.
  • Utilized standardized measures for adaptive, developmental, and cognitive functioning; employed descriptive and correlational analyses.

Main Results:

  • Adaptive skills and cognitive abilities generally fell in the low average to below average ranges.
  • Significant associations were found between adaptive skills and both developmental and cognitive functioning.
  • Lower adaptive skills correlated with genetic syndromes; higher adaptive skills linked to parental education. Females showed higher conceptual skills.

Conclusions:

  • Young children with CHD exhibit challenges in adaptive functioning, closely tied to their cognitive and developmental profiles.
  • Genetic syndromes and parental education are significant factors influencing adaptive skills in this group.
  • Findings underscore the need for targeted interventions to support adaptive development in children with CHD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
558
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
488
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
687
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
441